Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.